human lactoferrin peptide 1-11

DRUG2 trials

Sponsors

AM-Pharma

Conditions

BacteremiaBacterial Infections and MycosesHematopoietic Stem Cell TransplantationStaphylococcal Infections

Phase 1

Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients

CompletedNCT00509938

AM-PharmaBacterial Infections and Mycoses, Hematopoietic Stem Cell Transplantation

Start: 2006-03-31End: 2006-11-30Updated: 2008-10-17

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis

WithdrawnNCT00509847

AM-PharmaBacteremia, Staphylococcal Infections

Start: 2009-02-28End: 2009-10-31Updated: 2014-05-28